4//SEC Filing
Bruno Michael Anthony 4
Accession 0001415889-23-015123
CIK 0001651561other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:44 PM ET
Size
19.0 KB
Accession
0001415889-23-015123
Insider Transaction Report
Form 4
Bruno Michael Anthony
CHIEF ACCOUNTING OFFICER
Transactions
- Disposition to Issuer
Common Stock
2023-11-03−8,645→ 14,310 total - Disposition to Issuer
Common Stock
2023-11-03−12,960→ 1,350 total - Disposition to Issuer
Common Stock
2023-11-03−1,350→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-03−1,250→ 0 totalExercise: $55.13Exp: 2029-02-14→ Common Stock (1,250 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-03−2,500→ 0 totalExercise: $55.13Exp: 2029-02-14→ Common Stock (2,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-03−723→ 0 totalExercise: $54.76Exp: 2029-03-05→ Common Stock (723 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-03−527→ 0 totalExercise: $54.76Exp: 2029-03-05→ Common Stock (527 underlying)
Footnotes (7)
- [F1]Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 8,645 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $90,772.50, representing the product obtained by multiplying (x) aggregate number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50).
- [F2]Upon the consummation of the Merger, pursuant to the Merger Agreement, 12,960 outstanding restricted stock units ("RSUs") were cancelled and converted into the right to receive a cash payment of $136,080, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSUs, by (y) the offer price ($10.50).
- [F3]Upon the consummation of the Merger, pursuant to the Merger Agreement, 1,350 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $14,175, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50).
- [F4]Pursuant to the Merger Agreement, any stock option with an exercise price per share of Common Stock that was equal to or greater than the offer price ($10.50) was to be cancelled for no consideration. Accordingly, upon the consummation of the Merger, 1,250 stock options were cancelled for no consideration, as the exercise price per share of Common Stock was $55.13.
- [F5]Pursuant to the Merger Agreement, any stock option with an exercise price per share of Common Stock that was equal to or greater than the offer price ($10.50) was to be cancelled for no consideration. Accordingly, upon the consummation of the Merger, 2,500 stock options were cancelled for no consideration, as the exercise price per share of Common Stock was $55.13.
- [F6]Pursuant to the Merger Agreement, any stock option with an exercise price per share of Common Stock that was equal to or greater than the offer price ($10.50) was to be cancelled for no consideration. Accordingly, upon the consummation of the Merger, 723 stock options were cancelled for no consideration, as the exercise price per share of Common Stock was $54.76.
- [F7]Pursuant to the Merger Agreement, any stock option with an exercise price per share of Common Stock that was equal to or greater than the offer price ($10.50) was to be cancelled for no consideration. Accordingly, upon the consummation of the Merger, 527 stock options were cancelled for no consideration, as the exercise price per share of Common Stock was $54.76.
Documents
Issuer
Tabula Rasa HealthCare, Inc.
CIK 0001651561
Entity typeother
Related Parties
1- filerCIK 0001989188
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 8:44 PM ET
- Size
- 19.0 KB